The global vasectomy market has been estimated to grow at a high CAGR during the forecast period [2020-2026]. Vasectomy refers to a permanent procedure of stopping fertilization as process reversal is costly and often does not restore the male potency. Vasectomies can be performed by several methods, such as, open or conventional vasectomy, no-scalpel techniques or minimal invasive technique. The procedure of vasectomy is relatively easy. Most patients of the procedure can resume their sexual behaviour within a week with little to no discomfort.

With the advancement in the minimal invasive procedure, demand for open ended surgery has reduced. The advantages of minimal invasive surgical procedures include lesser hospital stay, low trauma and surgical footprint and lesser pain.

The global vasectomy market could be classified into type, drugs, end user, and patients. On the basis of type, the market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy. Secondly, with respect to drugs, the global vasectomy market has been segmented as anaesthetics, painkillers, antibiotics, and others. Thirdly, the market has been segmented as human and animals, on the basis of patients. Lastly, on the basis of end-user, the market has been segmented as hospitals and clinics, research and academics, and others.

Global Vasectomy Market

The global vasectomy market has seen increasing demands due to side effects of female contraception (namely, risk of cancer, hormonal disturbances, osteoporosis, rise in body weight and so forth), high safety profile of vasectomy and its simplicity over tubectomy such as lower cost, low rates of infection, simplicity and lesser duration at hospital. However, the market comprises several restraints including the complications, such as, risk of bleeding, infections, inadequate awareness, male superiority complexes paired with the non-reversible nature of vasectomy, social taboo, particularly in the emerging nations.

Some of the key players in the global vasectomy market include Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sklar Surgical Instruments, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Advanced Meditech International and many others.

Region-wise, North America accounts for a significant market share of the global vasectomy market owing to high expenditure on the health care. The US and Canada have seen greater number of vasectomies owing to greater male female equality. Higher concentration of the well-equipped hospitals in the developed countries of this region coupled with good reimbursement rates is also driving the market growth. Canada has a higher rate of people undergoing vasectomies than the U.S.

Europe is the second largest market in the world due to its growing pharmaceutical and industrial base. The European vasectomy market growth is led by Germany and France. Germany is anticipated to be the fastest growing market during the forecast period. Belgium, Denmark, and Switzerland also have higher rate of people undergoing vasectomies.

Asia Pacific region is likely to expand as well. China and India are likely to lead this market. India was the first nation in the world to include population control as a national program back in 1952. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future vasectomy market in the region.

Check the report description @: Global Vasectomy Market Size, Trends & Analysis - Forecasts to 2026